Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo‐controlled, double‐blind, noninferiority study. J

Ulrike Blume-Peytavi; Zahida Issiakhem; Stephanie Gautier; J. Kottner; Walter Wigger-Alberti; Tobias Fischer; Rolf Hoffmann; Francoise Tonner; Athmane Bouroubi; Jean-Jacques Voisard

doi:10.1111/jocd.12541

Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo‐controlled, double‐blind, noninferiority study. J

Ulrike Blume-Peytavi
, Zahida Issiakhem
, Stephanie Gautier
, J. Kottner
, Walter Wigger-Alberti
, Tobias Fischer
, Rolf Hoffmann
, Francoise Tonner
, Athmane Bouroubi
, Jean-Jacques Voisard

Department of Dermatology and Venereology

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	215-220
Number of pages	6
Journal	Journal of Cosmetic Dermatology
Issue number	18
DOIs	https://doi.org/10.1111/jocd.12541
Publication status	Published - 2019

Fields of science

302087 Venereology
302011 Dermatology

Access to Document

10.1111/jocd.12541

Cite this

Blume-Peytavi, U., Issiakhem, Z., Gautier, S., Kottner, J., Wigger-Alberti, W., Fischer, T., Hoffmann, R., Tonner, F., Bouroubi, A., & Voisard, J.-J. (2019). Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo‐controlled, double‐blind, noninferiority study. J. Journal of Cosmetic Dermatology, (18), 215-220. https://doi.org/10.1111/jocd.12541

@article{f57e7e44f1da46c4a6302d73277c8f40,

title = "Efficacy and safety of a new 5\% minoxidil formulation in male androgenetic alopecia: A randomized, placebo‐controlled, double‐blind, noninferiority study. J",

author = "Ulrike Blume-Peytavi and Zahida Issiakhem and Stephanie Gautier and J. Kottner and Walter Wigger-Alberti and Tobias Fischer and Rolf Hoffmann and Francoise Tonner and Athmane Bouroubi and Jean-Jacques Voisard",

year = "2019",

doi = "10.1111/jocd.12541",

language = "English",

pages = "215--220",

journal = "Journal of Cosmetic Dermatology",

issn = "1473-2165",

number = "18",

}

Blume-Peytavi, U, Issiakhem, Z, Gautier, S, Kottner, J, Wigger-Alberti, W, Fischer, T, Hoffmann, R, Tonner, F, Bouroubi, A & Voisard, J-J 2019, 'Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo‐controlled, double‐blind, noninferiority study. J', Journal of Cosmetic Dermatology, no. 18, pp. 215-220. https://doi.org/10.1111/jocd.12541

TY - JOUR

T1 - Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo‐controlled, double‐blind, noninferiority study. J

AU - Blume-Peytavi, Ulrike

AU - Issiakhem, Zahida

AU - Gautier, Stephanie

AU - Kottner, J.

AU - Wigger-Alberti, Walter

AU - Fischer, Tobias

AU - Hoffmann, Rolf

AU - Tonner, Francoise

AU - Bouroubi, Athmane

AU - Voisard, Jean-Jacques

PY - 2019

Y1 - 2019

UR - https://www.scopus.com/pages/publications/85045716331

U2 - 10.1111/jocd.12541

DO - 10.1111/jocd.12541

M3 - Article

SN - 1473-2165

SP - 215

EP - 220

JO - Journal of Cosmetic Dermatology

JF - Journal of Cosmetic Dermatology

IS - 18

ER -

Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo‐controlled, double‐blind, noninferiority study. J

Fields of science

Access to Document

Other files and links

Cite this